Assignee
COHERUS BIOSCIENCES INC
US·76 granted patents·33 pending applications·782 citations·filing 2012–2023
Top patents by PatentIndex Score
109 records- 0198US10716852B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Jul 21, 2020·10 cites·22 claims
- 0298US10155039B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted Dec 18, 2018·21 cites·12 claims
- 0398US9861695B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Jan 9, 2018·31 cites·25 claims
- 0498US9808525B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted Nov 7, 2017·24 cites·11 claims
- 0598US9789185B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Oct 17, 2017·23 cites·27 claims
- 0698US9782480B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Oct 10, 2017·25 cites·10 claims
- 0798US9782479B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted Oct 10, 2017·23 cites·20 claims
- 0898US9770507B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Sep 26, 2017·25 cites·8 claims
- 0998US9757454B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Sep 12, 2017·23 cites·29 claims
- 1098US9737600B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Aug 22, 2017·25 cites·9 claims
- 1198US9731008B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Aug 15, 2017·26 cites·20 claims
- 1298US9731009B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Aug 15, 2017·25 cites·8 claims
- 1398US9724415B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Aug 8, 2017·25 cites·10 claims
- 1498US9724414B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted Aug 8, 2017·23 cites·25 claims
- 1598US9707293B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Jul 18, 2017·25 cites·15 claims
- 1698US9682145B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Jun 20, 2017·23 cites·29 claims
- 1798US9382317B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted Jul 5, 2016·55 cites·10 claims
- 1898US9346880B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted May 24, 2016·44 cites·20 claims
- 1998US9340611B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted May 17, 2016·43 cites·12 claims
- 2098US9340612B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted May 17, 2016·42 cites·20 claims
- 2197US10207000B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted Feb 19, 2019·16 cites·11 claims
- 2297US10195275B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Feb 5, 2019·15 cites·25 claims
- 2397US10159733B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted Dec 25, 2018·15 cites·9 claims
- 2497US10159732B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted Dec 25, 2018·15 cites·13 claims
- 2596US10722579B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Jul 28, 2020·5 cites·22 claims
- 2696US10716853B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Jul 21, 2020·5 cites·22 claims
- 2796US10716854B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Jul 21, 2020·5 cites·22 claims
- 2895US9943601B2Etanercept formulations stabilized with combinations of sugars and polyolsCOHERUS BIOSCIENCES INC·Filed 2016·Granted Apr 17, 2018·12 cites·8 claims
- 2994US10799585B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Oct 13, 2020·2 cites·16 claims
- 3094US10772960B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Sep 15, 2020·2 cites·16 claims
- 3194US10772959B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Sep 15, 2020·2 cites·16 claims
- 3294US10688183B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Jun 23, 2020·2 cites·16 claims
- 3394US9770510B2Etanercept formulations stabilized with xylitolCOHERUS BIOSCIENCES INC·Filed 2016·Granted Sep 26, 2017·9 cites·18 claims
- 3494US9393305B2Etanercept formulations stabilized with xylitolCOHERUS BIOSCIENCES INC·Filed 2012·Granted Jul 19, 2016·13 cites·3 claims
- 3594US9302002B2Etanercept formulations stabilized with combinations of sugars and polyolsCOHERUS BIOSCIENCES INC·Filed 2012·Granted Apr 5, 2016·16 cites·8 claims
- 3693US10786566B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted Sep 29, 2020·2 cites·17 claims
- 3793US10780163B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted Sep 22, 2020·2 cites·29 claims
- 3892US10485869B2Etanercept formulations stabilized with meglumineCOHERUS BIOSCIENCES INC·Filed 2012·Granted Nov 26, 2019·7 cites·7 claims
- 3992US10376588B2Etanercept formulations stabilized with combinations of sugars and polyolsCOHERUS BIOSCIENCES INC·Filed 2018·Granted Aug 13, 2019·5 cites·13 claims
- 4092US10213508B2Etanercept formulations stabilized with xylitolCOHERUS BIOSCIENCES INC·Filed 2017·Granted Feb 26, 2019·5 cites·24 claims
- 4191US10293049B2Etanercept formulations stabilized with amino acidsCOHERUS BIOSCIENCES INC·Filed 2012·Granted May 21, 2019·8 cites·15 claims
- 4291US10286071B2Syringe containing stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted May 14, 2019·3 cites·20 claims
- 4391US10286072B2Methods of manufacturing stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted May 14, 2019·3 cites·20 claims
- 4491US9801942B2Etanercept formulations stabilized with metal ionsCOHERUS BIOSCIENCES INC·Filed 2012·Granted Oct 31, 2017·8 cites·24 claims
- 4590US10493151B2Etanercept formulations stabilized with sodium chlorideCOHERUS BIOSCIENCES INC·Filed 2012·Granted Dec 3, 2019·7 cites·11 claims
- 4690US9662396B2Stable aqueous formulations of etanerceptCOHERUS BIOSCIENCES INC·Filed 2015·Granted May 30, 2017·8 cites·4 claims
- 4789US11667702B2Stable aqueous formulations of afliberceptCOHERUS BIOSCIENCES INC·Filed 2019·Granted Jun 6, 2023·3 cites·30 claims
- 4889US10772865B2Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophyCOHERUS BIOSCIENCES INC·Filed 2020·Granted Sep 15, 2020·4 cites·15 claims
- 4987US11752225B2Systems and methods for producing sterile injection devicesCOHERUS BIOSCIENCES INC·Filed 2021·Granted Sep 12, 2023·7 cites·28 claims
- 5082US10987405B2Method of reducing formation of etanercept aggregates or fragmentsCOHERUS BIOSCIENCES INC·Filed 2019·Granted Apr 27, 2021·0 cites·20 claims
Showing the top 50 of 109 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when COHERUS BIOSCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →